Can further benefit be achieved by adding flosequinan to patients with congestive heart failure who remain symptomatic on diuretic, digoxin, and an angiotensin converting enzyme inhibitor? Results of the flosequinan-ACE inhibitor trial (FACET). (Q41071699)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Can further benefit be achieved by adding flosequinan to patients with congestive heart failure who remain symptomatic on diuretic, digoxin, and an angiotensin converting enzyme inhibitor? Results of the flosequinan-ACE inhibitor trial (FACET). |
scientific article |
Statements
1 reference
Can further benefit be achieved by adding flosequinan to patients with congestive heart failure who remain symptomatic on diuretic, digoxin, and an angiotensin converting enzyme inhibitor? Results of the flosequinan-ACE inhibitor trial (FACET). (English)
1 reference
Massie BM
1 reference
Berk MR
1 reference
Brozena SC
1 reference
Elkayam U
1 reference
Plehn JF
1 reference
Kukin ML
1 reference
Packer M
1 reference
Murphy BE
1 reference
Neuberg GW
1 reference
Steingart RM
1 reference
1 August 1993
1 reference
1 reference
88
1 reference
2
1 reference
492-501
1 reference
Identifiers
1 reference
1 reference